`Wells, Maclain
`Fleming, Michael; Parmelee, Steve; Gerrard, Sonja
`RE: IPR2018-00739, -00680--Marked Up Exhibits
`Wednesday, April 24, 2019 5:07:28 PM
`
`From:
`To:
`Cc:
`Subject:
`Date:
`
`Maclain,
`
`There are critical aspects of your stated request that are unaddressed, such as basis, timing and
`briefing length. I can make availability to have a discussion tomorrow morning.
`
`In addition, we should discuss the fact that the exhibits and material you’re identifying are primarily
`composed of Petitioner’s own publications – those publications expressly contradict arguments that
`were advanced in Petitioner’s Reply materials. Such references should have been disclosed to us
`(see 37 CFR 42.51(b)(1)(iii))—but never were disclosed to us (and possibly withheld from your own
`witness)—and certainly should be of record in these proceedings so that the Board can assess the
`credibility of Petitioner’s witness and the Reply arguments.
`
`It is also appropriate that Patent Owner be accorded corresponding briefing in a motion for the
`appropriate sanctions (e.g., 37 CFR 42.12(a)(1)-(3), (6)) for Petitioner’s failure to comply with
`discovery requirements and the corresponding frivolous/misleading argument in the Reply
`materials. Additionally, if Petitioner is authorized to file a motion to strike, Patent Owner should be
`authorized to file an opposition to that motion.
`
`In our meet/confer, please be prepared to clarify the noted aspects of your requested briefing and
`state whether you oppose/do not oppose Patent Owner’s requested briefing.
`
`Best regards,
`
`- Mike
`
`From: Wells, Maclain [mailto:MWells@irell.com]
`Sent: Wednesday, April 24, 2019 1:30 PM
`To: Rosato, Michael
`Cc: Fleming, Michael; Parmelee, Steve; Gerrard, Sonja
`Subject: RE: IPR2018-00739, -00680--Marked Up Exhibits
`
`Mike,
`
`Do you have time to meet and confer today? We will notify the Board of our request for
`authorization today and would like to have Protiva’s position. I am available this afternoon.
`
`Thanks,
`Maclain
`
`From: Rosato, Michael <mrosato@wsgr.com>
`Sent: Wednesday, April 24, 2019 11:47 AM
`
`1
`Exhibit 3002
`
`
`
`To: Wells, Maclain <MWells@irell.com>
`Cc: Fleming, Michael <MFleming@irell.com>; Parmelee, Steve <sparmelee@wsgr.com>; Gerrard,
`Sonja <sgerrard@wsgr.com>
`Subject: RE: IPR2018-00739, -00680--Marked Up Exhibits
`
`Maclain,
`
`Let’s set up a time to meet/confer. Does 2pm on Friday work for you?
`
`Best regards,
`
`
`- Mike
`
`
`From: Wells, Maclain [mailto:MWells@irell.com]
`Sent: Wednesday, April 24, 2019 9:17 AM
`To: Rosato, Michael
`Cc: Fleming, Michael; Parmelee, Steve; Gerrard, Sonja
`Subject: RE: IPR2018-00739, -00680--Marked Up Exhibits
`
`Mike,
`
`We intend to request authorization from the Board to file a motion to strike portions of Patent
`Owner’s sur-reply regarding the ’435 patent, including new exhibits 2046-2052 and new arguments
`presented for the first time in the sur-reply, including new arguments regarding the ‘554 publication
`at 11, n. 7, test data from new references at 19-20 & 25-26, test data from experiments in the ‘435
`patent not previously referenced (Examples 7-11) at 19-22, and other discussions of new references
`with regard to cationic lipid content at 27-29. Please let me know if Patent Owner opposes this
`request.
`
` I
`
` will give you a call on the exhibit issue raised below.
`
`
`Regards,
`Maclain
`
`
`From: Rosato, Michael <mrosato@wsgr.com>
`Sent: Monday, April 22, 2019 12:20 PM
`To: Wells, Maclain <MWells@irell.com>
`Cc: Fleming, Michael <MFleming@irell.com>; Parmelee, Steve <sparmelee@wsgr.com>; Gerrard,
`Sonja <sgerrard@wsgr.com>
`Subject: IPR2018-00739, -00680--Marked Up Exhibits
`
`Maclain,
`
`In the course of preparing our last briefing, we noticed that you had filed marked up versions of
`several exhibits rather than clean versions. In particular, the exhibits for cross testimony from Dr.
`
`2
`Exhibit 3002
`
`
`
`Thompson and Dr. Heyes includes various highlighting notations. Examples are noted below for your
`review of these exhibits:
`
`IPR2018-00739
`EX1019—Dr. Thompson Deposition, Vol. 1. Pages 13-15, among others.
`EX1020— Dr. Thompson Deposition, Vol. 2. Pages 215, 224 among others
`
`IPR2018-00680
`EX1023—Dr. Thompson Deposition, Vol. 1. Pages 13-15, among others.
`EX1024—Dr. Thompson Deposition, Vol. 2. Pages 291-293, among others.
`EX1026—Dr. Heyes Deposition. Pages 11, 20-21, among others
`
` I
`
` suspect this was an inadvertent submission so wanted to bring to your attention. Also, since we
`will need clean versions of transcripts on the record (sans highlighting) and these are petitioner’s
`exhibits, can you please attend to filing replacement copies? I think you’ll need to send the Board an
`email seeking authorization to file replacement exhibits for these, and asking that those originally
`filed be expunged. Obviously, you can note we don’t oppose the replacement.
`
`Thanks and of course feel free to call if any discussion is helpful.
`
`Best regards,
`
`
`- Mike
`
`
`Michael T Rosato
`Wilson Sonsini Goodrich & Rosati
`[o] 206.883.2529 | [f] 206.883.2699
`mrosato@wsgr.com
`
`
`
`This email and any attachments thereto may contain private, confidential, and privileged
`material for the sole use of the intended recipient. Any review, copying, or distribution of this
`email (or any attachments thereto) by others is strictly prohibited. If you are not the intended
`recipient, please contact the sender immediately and permanently delete the original and any
`copies of this email and any attachments thereto.
`
`PLEASE NOTE: This message, including any attachments, may include privileged,
`confidential and/or inside information. Any distribution or use of this communication by
`anyone other than the intended recipient(s) is strictly prohibited and may be unlawful. If you
`are not the intended recipient, please notify the sender by replying to this message and then
`delete it from your system. Thank you.
`
`3
`Exhibit 3002
`
`